Broomfield, CO, United States of America

Melissa Varner

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Galen Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Melissa Varner. Retrieved from https://idiyas.com/inventor/melissa-varner

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Melissa Varner: Inventor of an Injectable Tranexamic Acid Composition.

Introduction

Melissa Varner is an inventor associated with Broomfield, Colorado. Her patent work concerns concentrated tranexamic acid compositions designed for emergency treatment of severe bleeding.

Latest Patents

Varner is named on 1 patent: “Concentrated Injectable Tranexamic Acid Compositions and Methods of Use Thereof.” The invention describes concentrated tranexamic acid compositions suitable for intramuscular administration using an auto-injector. It also covers methods for treating non-compressible hemorrhage, as well as kits and auto-injectors containing the compositions.

Career Highlights

Varner is associated with Galen Limited. Her patent reflects work on a delivery approach intended to make tranexamic acid available through an auto-injector for potential use in treating serious bleeding.

Collaborations

Varner’s listed coworkers include Amir Genosar and Xicheng Sun. Their names are associated with the professional and inventive context surrounding her patent work.

Conclusion

Melissa Varner’s patent focuses on concentrated, auto-injector-compatible tranexamic acid compositions and their potential use in treating non-compressible hemorrhage.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…